Cargando…
Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
Elevated intraocular pressure (IOP) is a significant risk factor for the development and progression of glaucomatous optic neuropathy, but increasingly we appreciate that non-pressure dependent factors, are key to our understanding of the pathophysiology of these neurodegenerative diseases, that tar...
Autores principales: | Galanopoulos, Anna, Goldberg, Ivan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709013/ https://www.ncbi.nlm.nih.gov/pubmed/19668554 |
Ejemplares similares
-
Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006) -
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
por: Nguyen, Quang H
Publicado: (2014) -
Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
por: Gandolfi, Stefano A., et al.
Publicado: (2014) -
Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
por: Sharma, Sourabh, et al.
Publicado: (2015) -
Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to
a prostaglandin analog for open-angle glaucoma/ocular
hypertension
por: Topouzis, Fotis, et al.
Publicado: (2019)